GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium
Mammography innovations streamline exam workflows for patient-centered breast care
GE HealthCare's latest technologies include the Pristina Via™ mammography system, which provides effortless acquisition, operational excellence, and clinical confidence, which enhances the screening experience for both technologists and patients. This innovation, part of the Senographe Pristina™ platform, provides mammography technologists with a suite of sophisticated tools that balance the demands of diagnostic accuracy and fast-paced workflows to facilitate more patient-centered breast care.
Pristina Via, developed with technologists in mind, takes in-room workflow and patient comfort to the next level through zero-click acquisition functionality when acquiring within protocols, no wait time between exposures 1, and DBT image-to-image cycle times that are up to twice as fast as other mammography systems on the market. 2 Additionally, Pristina Via delivers vendor-neutral prior image comparison, reducing time spent analyzing previous exams and enabling final assessments more efficiently, and Pristina 3D STD mode has the lowest radiation dose for all thickness among the major systems available in the marketplace. 3,4
GE HealthCare to distribute DeepHealth's SmartMammo™ in the U.S. to streamline radiology workflows
GE HealthCare continues its strategic collaboration with DeepHealth Inc, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), to further the innovation, commercialization, and adoption of AI in imaging. The latest milestone includes the commercial availability of SmartMammo™, 510(k) cleared for use with Pristina in U.S. markets. GE HealthCare will distribute SmartMammo to imaging providers in the U.S. alongside the Pristina platform, allowing for integration of advanced AI directly into the company's comprehensive breast imaging portfolio.
AI continues to show great promise in breast cancer screening, from early detection and risk prediction to reduced callbacks and more efficient workflows for breast imaging providers. SmartMammo is an AI-powered SaaS solution designed to seamlessly integrate into existing breast cancer diagnostic workflows, enhancing diagnostic accuracy and workflow efficiencies. 5,6. SmartMammo facilitates fast image loading and real-time data rendering of multimodality images, accessible from any workstation and location and integrates directly into the customer's IT stack. DeepHealth's AI-powered breast cancer detection offers automatic lesion localization and degree of suspicion that are effective in diverse populations and dense breast tissue. 5 GE HealthCare's Pristina Via, combined with SmartMammo, provides workflow efficiency for both technologists and radiologists, as well as enhanced image interpretation features with automatic lesion localization.
'We are committed to delivering innovative technologies and end-to-end solutions that address our customer's biggest challenge in breast cancer detection, which is to help clinicians provide efficient, accurate and personalized diagnosis to patients,' says Pooja Pathak, Vice President and General Manager of Mammography at GE HealthCare. 'With Pristina Via and SmartMammo, we have streamlined both exam and radiology workflows in breast cancer screening and diagnostics, enabling clinicians to prioritize patient care.'
Latest advancements for breast cancer detection:
Invenia™ Automated Breast Ultrasound (ABUS) Premium, the first FDA-approved breast ultrasound indicated as an adjunct to mammography and specifically designed for detecting cancer in dense breasts, will also be showcased at the Symposium. According to studies across the U.S. and Europe, 40% of women and 70% of Asian women have dense breast tissue. 7,8 For patients with dense breasts, the addition of ABUS screening when used with mammography has demonstrated a 35.7% increase in cancer detection compared to mammography alone. 9 The latest Invenia ABUS Premium aims to deliver optimal outcomes with its innovative, patient-friendly, and efficient AI-driven technology. It features new integrated Verisound™ AI and AI Assistant 10, ensuring faster 11 and reproducible scanning and reading with extraordinary image quality. This increases clinical confidence, addresses workflow productivity, and aids in the detection of breast cancer in women with dense breasts.
SenoBright™ HD Contrast Enhanced Mammography (CEM) is a next-level mammogram that helps reduce the masking effect of fibroglandular breast tissue and increases the tumor signal to increase diagnostic confidence. It allows for imaging exams to be conducted in less than seven minutes and enables the detection of lesions that would otherwise go undetected 12, providing patients with answers right away to help them avoid the anxiety of an inconclusive exam.
Serena Bright™ is a contrast guided biopsy system that enables providers to see lesions using CEM and sample with certainty. This allows patients to undergo breast biopsy exams using the same mammography equipment, in a familiar setting, with familiar staff, to help relieve some of the stress of a biopsy procedure.
To learn more about the personalized breast cancer screening solutions GE HealthCare will be featuring at SBI 2025, please visit booth #407.
About GE HealthCare Technologies Inc.
GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits.
GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™.
Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.
1 Elapsed time between end of an exposure and system ready in DBT is 2.3s. Measured with ACR Phantom. Pristina Via performance measurement. Data on file GE HealthCare 2024.
2 Image to Image cycle time is the minimum waiting time by the System between two consecutive images. Measured with ACR phantoms for Pristina Via compared to claimed performance of competitor (Dimension 3D_ in Product Data Sheet from Jul-2024)
3 Phantom measurements as of July 2024. Senographe Pristina with default value STD mode.
4 Dose comparison based on NHS Breast Screening Programme equipment reports. https://medphys.royalsurrey.nhs.uk/nccpm/?s=technicalreports.
5 U.S. Food and Drug Administration. "Premarket Notification (510k) Summary: K243688." Accessed April 23, 2025. https://www.accessdata.fda.gov/cdrh_docs/pdf24/K243688.pdf.
6 Kim, J., et al. "Impact of a Categorical AI System for Digital Breast Tomosynthesis on Breast Cancer Interpretation by Both General Radiologists and Breast Imaging Specialists." Radiology: Artificial Intelligence (2024). https://doi.org/10.1148/ryai.230137.
7 Ellison-Loschmann, Lis, et al. 'Interactive and Independent Associations between the Socioeconomic and Objective Built Environment on the Neighbourhood Level and Individual Health: A Systematic Review of Multilevel Studies." PLOS ONE 8, no. 7 (2013): e123456. https://doi.org/10.1371/journal.pone.0123456.
8 FDA PMA P110006 summary of safety and effectiveness.
9 AI Assistant available third-party tools include QVCAD™, Koios DS™ Breast, BU-CAD™ and MONCAD ABS. Not available in all regions.
10 Compared to Invenia™ ABUS 2.0.
11 CEM guided biopsy can be performed within 15 minutes from first image to clip placement image. A shorter biopsy lead time and quicker biopsy procedure may speed up a definitive diagnosis and faster path to treatment. https://www.cedars-sinai.edu/Patients/Programs-and-Services/Imaging-Center/For-Patients/Exams-by-Procedure/MRI/MRGuided-Breast-Biopsy/MR-Guided-Breast-Needle-Core-Biopsy-Procedure-Information.aspx Data on file 2020, GE HealthCare.
12 Compared to without contrast
J. Sung et al., Radiology 2019; 00:1–8
V. Sorin et al. American Journal of Roentgenology: W267-W274. 10.2214/AJR.17.19355
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
25 minutes ago
- Business Wire
KBRA Assigns AA- Rating to Various Pennsylvania Turnpike Commission Turnpike Revenue Bonds; Affirms Related Ratings
NEW YORK--(BUSINESS WIRE)--KBRA assigns a long-term rating of AA- to the Pennsylvania Turnpike Commission: Turnpike Revenue Bonds, Series B-1 of 2025; Turnpike Revenue Bonds, Series B-2 of 2025; Turnpike Revenue Refunding Bonds, Third Series of 2025, Sub-series A; and, Turnpike Revenue Refunding Bonds, Third Series of 2025, Sub-series B. KBRA additionally affirms the long-term ratings of AA- for the Commission's outstanding Turnpike Revenue Bonds, A+ for the Commission's outstanding Turnpike Subordinate Revenue Bonds, and AA- for the Commission's outstanding Motor License Fund-Enhanced Turnpike Subordinate Special Revenue Bonds. The Outlook for each obligation is Stable. Key Credit Considerations The rating actions reflect the following key credit considerations: Credit Positives The Turnpike System is a highly essential, statewide, regional toll road system with limited competition. The Commission has full rate setting autonomy which, together with prudent finance management and controls, has supported strong margins and stable debt service coverage. Credit Challenges The Commission's O&M, capital and existing debt obligations, including its outstanding Act 44/89 obligations, are substantial and require annual toll increases, the cumulative effect of which may at some point dampen traffic demand, reducing operating margins and financial flexibility. The planned issuance of $3.6 billion in senior obligations per the 10-year capital plan may pressure subordinate obligation coverage if actual traffic demand is materially weaker than forecast, although the Commission's capital plans remain flexible if traffic volumes are not consistent with forecasts. Rating Sensitivities For Upgrade A sustained trend of increasing net revenue resulting in debt service coverages well in excess of the Commission's targets of 2.0x annual debt service on senior lien, 1.30x combined annual senior and subordinate debt service and 1.20x annual debt service for all obligations. For Downgrade A sustained decline in net revenue DSCRs below the Commission's targets for all obligations. To access ratings and relevant documents, click here. Methodologies Public Finance: U.S. Public Toll Roads, Bridges & Tunnels Revenue Bond Rating Methodology Public Finance: U.S. Special Tax Revenue Bond Rating Methodology ESG Global Rating Methodology Disclosures A description of all substantially material sources that were used to prepare the credit rating and information on the methodology(ies) (inclusive of any material models and sensitivity analyses of the relevant key rating assumptions, as applicable) used in determining the credit rating is available in the Information Disclosure Form(s) located here. Information on the meaning of each rating category can be located here. Only those ratings on securities issued by this Issuer that also are denoted on the Security Ratings tab for this Issuer on as 'endorsed' by Kroll Bond Rating Agency Europe Limited into the European Union and/or by Kroll Bond Rating Agency UK Limited into the UK are covered by the disclosures set forth in this press release and the corresponding Information Disclosure Form. No other ratings on issuances by this Issuer have been endorsed into the European Union or the UK, and the disclosures set forth herein and in the corresponding Information Disclosure Form are inapplicable to those ratings and may not be used for regulatory purposes by European Union or UK investors in these securities. Further disclosures relating to this rating action are available in the Information Disclosure Form(s) referenced above. Additional information regarding KBRA policies, methodologies, rating scales and disclosures are available at About KBRA Kroll Bond Rating Agency, LLC (KBRA), one of the major credit rating agencies (CRA), is a full-service CRA registered with the U.S. Securities and Exchange Commission as an NRSRO. Kroll Bond Rating Agency Europe Limited is registered as a CRA with the European Securities and Markets Authority. Kroll Bond Rating Agency UK Limited is registered as a CRA with the UK Financial Conduct Authority. In addition, KBRA is designated as a Designated Rating Organization (DRO) by the Ontario Securities Commission for issuers of asset-backed securities to file a short form prospectus or shelf prospectus. KBRA is also recognized as a Qualified Rating Agency by Taiwan's Financial Supervisory Commission and is recognized by the National Association of Insurance Commissioners as a Credit Rating Provider (CRP) in the U.S. Doc ID: 1010958
Business Wire
25 minutes ago
- Business Wire
ROVR Releases Open Dataset to Power the Future of Spatial AI, Robotics, and Autonomous Systems
SAN JOSE, Calif.--(BUSINESS WIRE)--At the ADAS & Autonomous Vehicle Technology Summit North America Booth 4030, ROVR, a leading decentralized physical infrastructure network (DePIN), will announce the ROVR Open Dataset — a high-resolution, multi-modal dataset designed to drive innovation in Spatial AI, autonomous driving, robotics, and digital twin applications. The dataset provides LiDAR point clouds, high-resolution video, IMU motion data, and centimeter-level RTK — all collected by ROVR's custom hardware through a global contributor network. The initial release includes 1,300 synchronized clips (1TB) spanning urban, suburban, and highway environments, with diverse conditions such as construction zones, school crossings, and dense traffic. All data is anonymized to protect privacy. 'Spatial AI is the next frontier of artificial intelligence,' said Guang Ling, Founder of ROVR. 'By making real-world, multi-modal driving data openly available, we aim to empower researchers and developers worldwide to build safer, smarter, and more generalizable AI systems.' The dataset is released for non-commercial use under a permissive license, with future versions to include full sequences, annotations, and commercial licensing options. ROVR's community-powered network has already achieved 25 million km of road coverage and deployed over 2,000 devices globally. This launch reflects ROVR's mission to democratize access to real-world 3D data, foster collaboration, and accelerate the responsible development of AI systems that understand and interact with the physical world. Access the Dataset: About ROVR ROVR is the cornerstone of Spatial AI — a decentralized network that transforms everyday vehicles into intelligent 3D mappers of the physical world. By collecting, structuring, and distributing large-scale 3D data, ROVR supports applications across AI, robotics, autonomous navigation, and beyond.
Business Wire
25 minutes ago
- Business Wire
Power Integrations Rolls Out Reference Design Kit for Solar Race Cars Featuring High-Efficiency Gallium-Nitride IC
DARWIN, Australia & SAN JOSE, Calif.--(BUSINESS WIRE)--Power Integrations is rolling out a new reference design kit tailored specifically for solar-powered race cars as 37 student teams prepare to race across the Outback in the Bridgestone World Solar Challenge starting August 24. The kit, RDK-85SLR, features the PI™ InnoSwitch™3-AQ IC , which incorporates PI's PowiGaN™ gallium-nitride switch technology. The kit is inspired by a design created by PI's PowerPros ℠ online support engineers in collaboration with the ETH Zurich aCentauri team, whose #85 'Silvretta' challenger-class car is using the design to maximize efficiency in its auxiliary power supply. 'Thousands of engineering students participate in solar car challenges around the world each year, and these innovators will help bring about a more sustainable future,' said Andy Smith, director of technical outreach and training for Power Integrations. 'We are providing this reference kit to help young engineers take advantage of the latest, most energy-efficient technologies, such as PowiGaN, in their designs.' The design kit includes everything needed to create a 46-watt power supply that delivers up to 80 watts for short periods—making it ideal for use as an auxiliary power supply in a solar race car. It employs the company's InnoSwitch3-AQ flyback power supply IC with a highly efficient PowiGaN switch and eliminates the need for a heatsink, enabling more compact, lightweight, and cost-effective designs. Contents of the kit include a sample power supply, four InnoSwitch3-AQ ICs, and an unpopulated PCB. It is backed by a report containing power supply and magnetics transformer build instructions, schematics, a PCB layout guide, a parts list and comprehensive performance data. Live tech support is available from Power Integrations' PowerPros team. 'We proved PowiGaN's reliability, performance and efficiency in the Bridgestone World Solar Challenge in 2023,' stated Aaron Griesser, lead electrical engineer from the 2023 aCentauri team. 'We achieved 95 percent efficiency across both light and full loads with a broad output range of 5 to 60 W. Additionally, the scrutineering judges were astounded to see an auxiliary power supply without a heatsink.' Power Integrations is a proud sponsor of the aCentauri team and will be reporting on the race from Mr. Green's Blog and PI's social media channels using hashtag #PowiGaNVan. Availability & Resources Reference design kit RDK-85SLR is priced at $50. Solar race car teams can get the kit free by registering online. About Power Integrations Power Integrations, Inc., is a leading innovator in semiconductor technologies for high-voltage power conversion. The company's products are key building blocks in the clean-power ecosystem, enabling the generation of renewable energy as well as the efficient transmission and consumption of power in applications ranging from milliwatts to megawatts. For more information, please visit Power Integrations, the Power Integrations logo, PI, PowiGaN, PowerPros and InnoSwitch3-AQ are trademarks, service marks or registered trademarks of Power Integrations, Inc. All other trademarks are the property of their respective owner.
